Centaurin-α1-ras-elk-1 signaling at mitochondria mediates β-amyloid-induced synaptic dysfunction

Annals of Internal Medicine

Volumn 158, Issue 6, 2013, Pages 5367-5374

  Szatmari, Erzsebet M ^a   Oliveira, Ana F ^b   Sumner, Elizabeth J ^c   Yasuda, Ryohei ^d  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d MAX PLANCK FLORIDA INSTITUTE FOR NEUROSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CENTAURIN ALPHA 1; LUCIFERASE; MITOCHONDRIAL PROTEIN; NUCLEAR PROTEIN; NUCLEOTIDE BINDING PROTEIN; RAS PROTEIN; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CELL LOSS; CONTROLLED STUDY; DENDRITIC SPINE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; LASER MICROSCOPY; MALE; MITOCHONDRION; MOUSE; NERVE CELL PLASTICITY; NEUROPATHY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; RAT; SIGNAL TRANSDUCTION; SYNAPTIC DYSFUNCTION; SYNAPTIC TRANSMISSION; UPREGULATION; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CELLS, CULTURED; DENDRITIC SPINES; ETS-DOMAIN PROTEIN ELK-1; EXCITATORY POSTSYNAPTIC POTENTIALS; GTPASE-ACTIVATING PROTEINS; HIPPOCAMPUS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MITOCHONDRIA; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; NEURONS; RAS PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES;

EID: 84875170796     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Aggensteiner M, Reiser G (2003) Expression of the brain-specific membrane adapter protein p42IP4/centaurin alpha, a Ins(1,3,4,5)P4/ PtdIns(3,4,5)P3 binding protein, in developing rat brain. Brain Res Dev Brain Res 142:77-87.
2. Almeida CG, Tampellini D, Takahashi RH, Greengard P, Lin MT, Snyder EM, Gouras GK (2005) Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis 20:187-198.
3. Barrett LE, Van Bockstaele EJ, Sul JY, Takano H, Haydon PG, Eberwine JH (2006) Elk-1 associates with the mitochondrial permeability transition pore complex in neurons. Proc Natl Acad Sci USA 103:5155-5160.
4. Calabrese B, Shaked GM, Tabarean IV, Braga J, Koo EH, Halpain S (2007) Rapid, concurrent alterations in preand postsynaptic structure induced by naturally-secreted amyloid-beta protein. Mol Cell Neurosci 35:183-193.
5. Clements JD, Bekkers JM (1997) Detection of spontaneous synaptic events with an optimally scaled template. Biophys J 73:220-229.
6. Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, Molkentin JD, Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX, Yan SD (2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 14:1097-1105.
7. Eckert A, Hauptmann S, Scherping I, Meinhardt J, Rhein V, Drose S, Brandt U, Fandrich M, Müller WE, Gotz J (2008) Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice. J Mol Med 86:1255-1267.
8. +. J Neurochem 109:1701-1713.
9. Hammonds-Odie LP, Jackson TR, Profit AA, Blader IJ, Turck CW, Prestwich GD, Theibert AB (1996) Identification and cloning of centaurin-alpha. A novel phosphatidylinositol 3,4,5-trisphosphate-binding protein from rat brain. J Biol Chem 271:18859-18868.
10. Hansson Petersen CA, Alikhani N, Behbahani H, Wiehager B, Pavlov PF, Alafuzoff I, Leinonen V, Ito A, Winblad B, Glaser E, Ankarcrona M (2008) The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci USA 105:13145-13150.
11. Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12:383-388.
12. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356.
13. Harvey CD, Yasuda R, Zhong H, Svoboda K (2008) The spread of Ras activity triggered by activation of a single dendritic spine. Science 321:136-140.
14. Hayashi H, Matsuzaki O, Muramatsu S, Tsuchiya Y, Harada T, Suzuki Y, Sugano S, Matsuda A, Nishida E (2006) Centaurin-alpha1 is a phosphatidylinositol 3-kinase-dependent activator of ERK1/2 mitogen-activated protein kinases. J Biol Chem 281:1332-1337.
15. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, Malinow R (2006) AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52:831-843.
16. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH, Bloom FE (2006) Earlyonset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 103:5161-5166.
17. Kalita K, Kharebava G, Zheng JJ, Hetman M (2006) Role of megakaryoblastic acute leukemia-1 inERK1/2-dependent stimulation ofserum response factor-driven transcription by BDNF or increased synaptic activity. J Neurosci 26:10020-10032.
18. Kreutz MR, Böckers TM, Sabel BA, Hülser E, Stricker R, Reiser G (1997) Expression and subcellular localization of p42IP4/centaurin-alpha, a brainspecific, high-affinity receptor for inositol 1,3,4,5-tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate in rat brain. Eur J Neurosci 9:2110-2124.
19. Lacor PN, Buniel MC, Furlow PW, Clemente AS, Velasco PT, Wood M, Viola KL, Klein WL (2007) Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci 27:796-807.
20. Lee SJ, Escobedo-Lozoya Y, Szatmari EM, Yasuda R (2009) Activation of CaMKII in single dendritic spines during long-term potentiation. Nature 458:299-304.
21. Matsuzaki M, Honkura N, Ellis-Davies GC, Kasai H (2004) Structural basis of long-term potentiation in single dendritic spines. Nature 429:761-766.
22. Mattson MP, Gleichmann M, Cheng A (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60:748-766.
23. McAllister AK (2000) Biolistic transfection of neurons. Sci STKE 2000:PL1.
24. Moolman DL, Vitolo OV, Vonsattel JP, Shelanski ML (2004) Dendrite and dendritic spine alterations in Alzheimer models. J Neurocytol 33:377-387.
25. Moore CD, Thacker EE, Larimore J, Gaston D, Underwood A, Kearns B, Patterson SI, Jackson T, Chapleau C, Pozzo-Miller L, Theibert A (2007) The neuronal Arf GAP centaurin alpha1 modulates dendritic differentiation. J Cell Sci 120:2683-2693.
26. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J Neurosci 20:4050-4058.
27. Murakoshi H, Wang H, Yasuda R (2011) Local, persistent activation of Rho GTPases during plasticity of single dendritic spines. Nature 472:100-104.
28. Origlia N, Righi M, Capsoni S, Cattaneo A, Fang F, Stern DM, Chen JX, Schmidt AM, Arancio O, Yan SD, Domenici L (2008) Receptor for advanced glycation end product-dependent activation of p38 mitogenactivated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction. J Neurosci 28:3521-3530.
29. Pei JJ, Tanaka T, Tung YC, Braak E, Iqbal K, Grundke-Iqbal I (1997) Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 56:70-78.
30. Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, Lo E, Wu D, Saule E, Bouschet T, Matthews P, Isaac JT, Bortolotto ZA, Wang YT, Collingridge GL (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53:703-717.
31. Pologruto TA, Sabatini BL, Svoboda K (2003) ScanImage: Flexible software for operating laser-scanning microscopes. Biomed Eng Online 2:13.
32. Reiser G, Bernstein HG (2002) Neurons and plaques of Alzheimer's disease patients highly express the neuronal membrane docking protein p42IP4/ centaurin alpha. Neuroreport 13:2417-2419.
33. Reiser G, Bernstein HG (2004) Altered expression of protein p42IP4/ centaurin-alpha 1 in Alzheimer's disease brains and possible interaction of p42IP4 with nucleolin. Neuroreport 15:147-148.
34. Rui Y, Gu J, Yu K, Hartzell HC, Zheng JQ (2010) Inhibition of AMPA re-ceptor trafficking at hippocampal synapses by beta-amyloid oligomers: the mitochondrial contribution. Mol Brain 3:10.
35. Serenó L, Coma M, Rodríguez M, Sánchez-Ferrer P, Sánchez MB, Gich I, Agulló JM, Pérez M, Avila J, Guardia-Laguarta C, Clarimón J, Lleó A, Gómez-Isla T (2009) A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo. Neurobiol Dis 35:359-367.
36. Sgambato V, Vanhoutte P, Pagès C, Rogard M, Hipskind R, Besson MJ, Caboche J (1998) In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain. J Neurosci 18:214-226.
37. Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866-2875.
38. Sharma A, Callahan LM, Sul JY, Kim TK, Barrett L, Kim M, Powers JM, Federoff H, Eberwine J (2010) A neurotoxic phosphoform of Elk-1 associates with inclusions from multiple neurodegenerative diseases. PLoS One 5:e9002.
39. Sheng M, Sabatini BL, Sudhof TC (2012) Synapses and Alzheimer's disease. Cold Spring Harb Perspect Biol 4.
40. Snyder EM, Nong Y, Almeida CG, Paul S, Moran T, Choi EY, Nairn AC, Salter MW, Lombroso PJ, Gouras GK, Greengard P (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci 8:1051-1058.
41. Stoppini L, Buchs PA, Muller D (1991) A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173-182.
42. Szatmari E, Kalita KB, Kharebava G, Hetman M (2007) Role of kinase suppressor of Ras-1 in neuronal survival signaling by extracellular signalregulated kinase 1/2. J Neurosci 27:11389-11400.
43. Tackenberg C, Brandt R (2009) Divergent pathways mediate spine alterations and cell death induced by amyloid-{beta}, wild-type tau, and R406W tau. J Neurosci 29:14439-14450.
44. Tong L, Balazs R, Thornton PL, Cotman CW (2004) Beta-amyloid peptide at sublethal concentrations downregulates brain-derived neurotrophic factor functions in cultured cortical neurons. J Neurosci 24:6799-6809.
45. Vanhoutte P, Barnier JV, Guibert B, Pagès C, Besson MJ, Hipskind RA, Caboche J (1999) Glutamate induces phosphorylation of Elk-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinasedependent pathway in brain slices. Mol Cell Biol 19:136-146.
46. Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X (2009) Impaired balanceof mitochondrial fission and fusion in Alzheimer's disease.J Neurosci 29:9090-9103.
47. Wei W, Nguyen LN, Kessels HW, Hagiwara H, Sisodia S, Malinow R (2010) Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat Neurosci 13:190-196.
48. Whitmarsh AJ, Shore P, Sharrocks AD, Davis RJ (1995) Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403-407.
49. Wu HY, Hudry E, Hashimoto T, Kuchibhotla K, Rozkalne A, Fan Z, SpiresJones T, Xie H, Arbel-Ornath M, Grosskreutz CL, Bacskai BJ, Hyman BT (2010) Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J Neurosci 30:2636-2649.
50. Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM, Boniface JJ, Smith R, Lessnick SL, Sahasrabudhe S, Stockwell BR (2007) RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447:864-868.